On November 8, 2009
Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better
Trius Therapeutics added its name to the initial public offering queue on Friday, apparently undeterred by the abysmal performance of Omeros Corp., the first true biotech to go public in the current IPO window.
0 Comments